secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001753926-24-000805
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella receives Nasdaq bid price deficiency notice; 180 days to cure
---------------------------------------------------------------------

- Nasdaq letter dated April 17, 2024, notes LIPO common stock closing bid price below $1.00 for 30 consecutive business days.
- Company has until October 14, 2024 to regain compliance; bid price must close at $1.00 or more for 10 consecutive business days.
- If not compliant by Oct 14, may qualify for additional 180-day grace period if meeting other Nasdaq Capital Market listing standards.
- Lipella intends to monitor bid price and evaluate available options to cure deficiency; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000805/0001753926-24-000805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000805/g084189_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-000805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer